Radiofrequency For Chronic Knee Pain Post-Arthroplasty
DEFIANT
Radiofrequency For The Treatment Of Chronic Knee Pain Following Total Knee Arthroplasty: A Double-Blind Randomized Controlled Pilot Study
1 other identifier
interventional
9
1 country
1
Brief Summary
Chronic knee osteoarthritis (OA) is one of the most common diseases with increasing prevalence in advanced age. Knee OA results in movement restriction, sleep disturbance, and disability. Total knee arthroplasty (TKA) is employed often in the symptomatic treatment of knee OA. It has been estimated that 3.4 million TKAs will be performed in the year 2030 in the United States alone. Many studies report rewarding outcomes for patients, but other research shows there are many patients that remain dissatisfied post-arthroplasty. The purpose of this study is to evaluate whether genicular radiofrequency ablation can relieve chronic post-arthroplasty knee pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2016
CompletedFirst Posted
Study publicly available on registry
October 13, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2018
CompletedDecember 13, 2018
December 1, 2018
2 years
October 5, 2016
December 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean difference in knee pain intensities as indicated on the Visual Analog Scale
Baseline and 6 weeks post-radiofrequency ablation
Secondary Outcomes (7)
Change in Visual Analog Score of average knee pain
Baseline to 1 week, 6 weeks, and 12 weeks
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Baseline to 1 week, 6 weeks, and 12 weeks
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Baseline to 1 week, 6 weeks, and 12 weeks
Change of Patient Global Assessment
Baseline to 1 week, 6 weeks, and 12 weeks
Satisfaction with Radiofrequency Procedure
Baseline to 1 week, 6 weeks, and 12 weeks
- +2 more secondary outcomes
Study Arms (2)
Nerve Block with Radiofrequency Ablation
ACTIVE COMPARATORA 10 cm 18-gauge RF cannula with a 10 mm active tip will be placed at the superior lateral, superior medial, and inferior medial nerve positions under fluoroscopic guidance. Sensory stimulation at 50 Hz will be performed to identify nerve position and to assure no motor nerves will be ablated. Lidocaine (2 ml of 2%) will be administered in each location prior to RF generator activation.
Nerve Block with Sham Radiofrequency Ablation
SHAM COMPARATORA 10 cm 18-gauge RF cannula with a 10 mm active tip will be placed at the superior lateral, superior medial, and inferior medial nerve positions under fluoroscopic guidance.Control patients will undergo the same procedure without RF generator activation. Sensory stimulation at 50 Hz will be performed to identify nerve position and to assure no motor nerves will be ablated. Lidocaine (2 ml of 2%) will be administered in each location prior to RF generator sham activation.
Interventions
Ablation of the genicular nerves of the knee by radiofrequency
Genicular radiofrequency of the knee without neurotomy
Eligibility Criteria
You may qualify if:
- Study candidate must provide written informed consent.
- Must be ≥ 50 years of age at the time of consent
- Chronic knee pain despite total knee arthroplasty at least 6 months prior to consent
- Orthopedic evaluation indicating no further surgery is warranted
- Stable pain medication regimen for 30 days prior to baseline visit
- Knee pain is primary pain complaint
You may not qualify if:
- Acute knee pain
- Connective tissue disorders affecting the knee
- Serious neurologic or psychiatric disorders that would affect the outcome of the study as determined by the Principal Investigator
- Steroid or hyaluronic acid injections into the affected knee in the past 3 months
- Confounding pain conditions of the index leg that may affect medication requirements or study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Randall Brewer, MD, CPIlead
- Abbott Medical Devicescollaborator
- Abbottcollaborator
Study Sites (1)
WK River Cities Clinical Research Center
Shreveport, Louisiana, 71105, United States
Related Publications (4)
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222.
PMID: 17403800BACKGROUNDNikolaou VS, Chytas D, Babis GC. Common controversies in total knee replacement surgery: Current evidence. World J Orthop. 2014 Sep 18;5(4):460-8. doi: 10.5312/wjo.v5.i4.460. eCollection 2014 Sep 18.
PMID: 25232522BACKGROUNDChoi WJ, Hwang SJ, Song JG, Leem JG, Kang YU, Park PH, Shin JW. Radiofrequency treatment relieves chronic knee osteoarthritis pain: a double-blind randomized controlled trial. Pain. 2011 Mar;152(3):481-487. doi: 10.1016/j.pain.2010.09.029. Epub 2010 Nov 4.
PMID: 21055873BACKGROUNDAl-Hadithy N, Rozati H, Sewell MD, Dodds AL, Brooks P, Chatoo M. Causes of a painful total knee arthroplasty. Are patients still receiving total knee arthroplasty for extrinsic pathologies? Int Orthop. 2012 Jun;36(6):1185-9. doi: 10.1007/s00264-011-1473-6. Epub 2012 Jan 11.
PMID: 22234706BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randall Brewer, MD
WK River Cities Clinical Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical Director, Principal Investigator
Study Record Dates
First Submitted
October 5, 2016
First Posted
October 13, 2016
Study Start
December 1, 2016
Primary Completion
November 20, 2018
Study Completion
November 30, 2018
Last Updated
December 13, 2018
Record last verified: 2018-12